ESTECH CLEARVIEW MV ATRIAL DEPRESSOR

K053021 · Estech, Inc. · DTS · Jan 26, 2006 · Cardiovascular

Device Facts

Record IDK053021
Device NameESTECH CLEARVIEW MV ATRIAL DEPRESSOR
ApplicantEstech, Inc.
Product CodeDTS · Cardiovascular
Decision DateJan 26, 2006
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.4420
Device ClassClass 2
AttributesTherapeutic

Intended Use

The ESTECH Clearview™ MV Atrial Depressor is intended to remove excess fluids from the surgical field for filtering and return to the patient during cardiopulmonary bypass of up to 6 hours. It can also be used to retract tissue to increase visibility.

Device Story

Sterile, single-use surgical instrument; collects blood/fluids from surgical field for return to cardiopulmonary bypass circuit; integrates with Estech Small Incision Retractor for thoracotomy/mini-sternotomy access; provides dual functionality of fluid suction and tissue retraction; used by surgeons in OR during stopped-heart procedures; improves visibility and maintains fluid balance.

Clinical Evidence

Bench testing only. Biocompatibility testing per ISO 10993 passed. Preclinical performance data provided to support labeled claims and demonstrate substantial equivalence.

Technological Characteristics

Molded polymer construction; integrated shaft for retractor mounting; sterile, single-use; passive suction via connection to cardiopulmonary bypass system.

Indications for Use

Indicated for patients undergoing open heart surgery requiring cardiopulmonary bypass (up to 6 hours) for fluid removal and tissue retraction to improve surgical field visibility.

Regulatory Classification

Identification

A cardiopulmonary bypass cardiotomy return sucker is a device that consists of tubing, a connector, and a probe or tip that is used to remove blood from the chest or heart during cardiopulmonary bypass surgery.

Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## Endoscopic Technologies, Inc. #### KOS 3021 RG 1 of 2 ESTECH Clearview MV Atrial Depressor Premarket Notification # Section 5: 510(k) Summary ### Device Information: | Category | Comments | |---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------| | Sponsor: | Estech<br>4135 Blackhawk Plaza Circle.<br>Suite 150<br>Danville, CA 94506<br>Tel: 925-648-3500 | | Correspondent Contact<br>Information: | Craig Coombs<br>Coombs Medical Device Consulting<br>1193 Sherman Street<br>Alameda, CA 94501<br>Tel: 510-337-0140<br>Fax: 510-337-0416 | | Device Common Name: | Cardiopulmonary bypass cardiotomy return sucker | | Device Classification & Code: | Class II, DTS (21 CFR 870.4420) | | Device Classification Name: | Sucker, Cardiotomy Return, Cardiopulmonary<br>Bypass | | Device Proprietary Name: | Estech Clearview™ MV Atrial Depressor | ### Predicate Device Information: | Predicate Devices: | California Medical Laboratories Rigid Tip<br>Suction Wands (K982891)<br>IBC Cardiac Suction Wand (K963756) | |-----------------------------------------|------------------------------------------------------------------------------------------------------------| | Predicate Device Manufacturers: | California Medical Laboratories<br>International Biophysics Corporation | | Predicate Device Common Name: | Cardiopulmonary bypass cardiotomy return<br>sucker | | Predicate Device Classification: | 21 CFR 870.4420 | | Predicate Device Classification & Code: | Class II, DTS | ### b. Date Summary Prepared 13 January 2006 #### c. Description of Device The Estech Clearview™ MV Atrial Depressor is a sterile, single use, surgical instruments intended for the collection of blood and other fluids from the surgical field for return through the cardiotomy system during open heart surgery. The a molded polymer proximal connector is intended to connect into cardiopulmonary bypass system to return blood and fluids into the extracorporeal circulation circuit, most typically during stoppedheart surgical procedures. The Estech Clearview™ MV Atrial Depressor has an integrated shaft designed to connect to the Estech Small Incision Retractor. The retractor creates access to the surgical field {1}------------------------------------------------ via thoracotomy or mini-sternotomy. When mounted to the retractor, the Estech Clearview™ MV Atrial Depressor can also be used to retract tissues while collecting fluids. ## d. Intended Use The ESTECH Clearview™ MV Atrial Depressor is intended to remove excess fluids from the surgical field for filtering and return to the patient during cardiopulmonary bypass of up to 6 hours. It can also be used to retract tissue to increase visibility. ## e. Comparison to Predicate Device The Estech Clearview™ MV Atrial Depressor is substantially equivalent in intended use. technology, design and materials to the predicate devices. The Estech Clearview™ MV Atrial Depressor is substantially equivalent to the California Medical Laboratories Rigid Tip Suction Wands (K982891) and the IBC Cardiac Suction Wand (K963756). The current and predicate devices are sterile, single use, surgical instruments intended for the collection of blood and other fluids from the surgical field for return through the cardiotomy system during open heart surgery. ## f. Summary of Supporting Data Biocompatibility testing consistent with ISO 10993 is presented in Section 15. All components of the Estech Clearview™MV Atrial Depressor passed the testing. Preclinical performance data was supplied to demonstrate that the Estech Clearview™M MV Atrial Depressor can meet its labeled performance claims, and to demonstrate substantial equivalence with the predicate device {2}------------------------------------------------ Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three lines representing its wings and body. The eagle is enclosed in a circle of text that reads "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA". Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JAN 2 6 2006 Coombs Medical Device Consulting c/o Mr. Craig Coombs President 1193 Sherman Street Alameda, CA 94501 Re: K053021 ESTECH Clearview™M MV Atrial Depressor Regulation Name: Cardiopulmonary Bypass Cardiotomy Return Sucker Regulatory Class: II Product Code: DTS Dated: January 10, 2006 Received: January 12, 2006 Dear Mr. Coombs: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstatc commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, I'DA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. Duna R. Lichner \ Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ KØ53Ø21 Endoscopic Technologies, Inc. ESTECH Clearview MV Atrial Depressor Requested Information - K053021 # Section 4: Indications for Use Statement 510(k) Number (if known): Ko53021 ESTECH Clearview™ MV Atrial Depressor Device Name: Indications For Use: The ESTECH Clearview™ MV Atrial Depressor is intended to remove excess fluids from the surgical field for filtering and return to the patient during cardiopulmonary bypass of up to 6 hours. It can also be used to retract tissue to increase visibility. Prescription Use _____________________________________________________________________________________________________________________________________________________________ AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Darra R. Vac Page 1 of ____________________________________________________________________________________________________________________________________________________________________ (Division Sign-Off) Division of Cardiovascular Devices 510(k) Number_k05302 | _______________________________________________________________________________________________________________________________________________________
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%